Don´t waste time to develop bioanalytical methods which we already might provide. Experience the advantages. All from a single source.
In 2010 we have been dealing with quantitative bioanalytics for more than 10 years. Our services range from hybridization assays to Real-Time RT-qPCR to detect your investigational new drugs based on nucleic acids chemistry (RNA/DNA). We also offer immunology assays to investigate immune response to nucleic acids therapeutics.
Advantages which will of course be handed over to our customers.
Just select from our ligand binding assay portfolio:
Solid phase hybridization assays.
for concomitant pharmacokinetics of novel therapeutics like: aptamers, small interfering RNAs (siRNA), micro RNAs, CpG oligonucleotides, antisense oligonucletides, ribozymes, plasmids, transcripts, etc
Liquid phase Real-Time RT-qPCR hybridization assays.
for pharmacokinetics of RNA or DNA therapeutics of any kind, support of pharmacodynamics in antibiotics research, gene expression profiling, single nucleotide polymorphism detection, etc
immunogenicity of novel drugs, complement activation, biomarker monitoring, inflammation response to novel drugs, support of pharmacodynamics in antibiotics research, immunoprecipitation, etc
Pharmacokinetics and Statistics.
Our all-in-one-hand service from the beginning also includes competent data management and analysis at the very end, regardless of which software or method you prefer.
Certainly all of these services are fully compliant to Good Laboratory Practice (GLP) regulations.